Market Overview

Genzyme Higher On Deal Rumors (GENZ)


dealREPORTER is reporting that Genzyme (NASDAQ: GENZ) is moving higher as unconfirmed sources are saying that a deal for the company can happen within the next couple of weeks.

Genzyme has been the target of Sanofi-Aventis (NYSE: SNY), which bid for the company, but was rebuffed by shareholders.

At last check, shares were down 20 cents to $71.50, but had been down much more than that earlier.

Posted-In: dealREPORTERM&A News Rumors


Related Articles (GENZ + SNY)

View Comments and Join the Discussion!

Market Continues Kung Fu Fighting 11-05-2010

Money Does Grow on Trees With These Stocks (PCL, PCH, RYN)